The first attempt to use therapies derived from human embryos on patients is coming to the San Francisco Bay Area as part of research that Menlo Park-based Geron Corp. hopes will cure spinal cord injuries.
Stanford Hospital and Santa Clara Valley Medical Center volunteered to become the third research site for the clinical trials and are now recruiting patients.
The first – and so far only – patient was injected with the Geron stem cell treatment at Shepherd Center in Atlanta in October. Northwestern University Medical Center in Chicago is also an approved site. Stanford, a world center for embryonic stem cell research, announced its participation in January.
This is the first human embryonic stem cell treatment on humans approved by the U.S. Food and Drug Administration. The primary goal of the clinical trials is to see if it is safe to treat human beings with cells cultured from the cells drawn from in-vitro fertilization embryos.